A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00744666` - IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids	Phase 4
Completed	`NCT06123923` - Trends of Vitreoretinal Surgery in Children
Completed	`NCT02477605` - Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes	N/A
Recruiting	`NCT06429969` - Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

See also

Status

Clinical Trial

Phase

Recruiting

NCT00744666 - IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids

Phase 4

Completed

NCT06123923 - Trends of Vitreoretinal Surgery in Children

Completed

NCT02477605 - Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes

N/A

Recruiting

NCT06429969 - Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06294613
Study type	Interventional
Source	Acusurgical
Contact	Charlene Braun
Phone	+33663334352
Email	charlene.braun@acusurgical.com
Status	Recruiting
Phase	N/A
Start date	February 8, 2024
Completion date	July 2024

A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms